Daclatasvir dihydrochloride

CAS: 1009119-65-6

Ref. TM-T1786

Informação sobre produto

• Nome: Daclatasvir dihydrochloride
• Sinónimos: BMS-790052 dihydrochloride, Bms 790052-05, Carbamic acid, N,N′-[[1,1′-biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C′-dimethyl ester, hydrochloride (1:2), Daclatasvir.2HCL, Daklinza, N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride
• CAS: 1009119-65-6

Descrição

Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has yet to be convincingly implicated in cases of clinically apparent liver injury with jaundice.

• Marca: Targetmol

Propriedades químicas

• Peso molecular: 811.8
• Fórmula: C₄₀H₅₂Cl₂N₈O₆
• Pureza: 99.84%
• Cor/forma: Solid